Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Seq84
    Member
    • Feb 2011
    • 19

    #1

    Duplicates percentage in target resequencing

    Hi,

    We are performing a target resequencing experiment, where we enriched 8 regions.
    1. What's the mean % of duplicates in this kind of experiments ?
    2. The % in duplicates is casual or is affected by specifics factors?
    3. During quality control analysis we noticed that % in duplicates range from 1 to 80%, is it normal have high % of duplicates in a target resequencing experiment?
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #2
    A high duplicate percentage comes from (generally) too many PCR cycles pre-hybridization. For standard exomes we typically see < 5% PCR duplicates using Agilent SureSelect.

    Comment

    • NGSfan
      Senior Member
      • Apr 2009
      • 181

      #3
      Originally posted by Heisman View Post
      A high duplicate percentage comes from (generally) too many PCR cycles pre-hybridization. For standard exomes we typically see < 5% PCR duplicates using Agilent SureSelect.

      5% is impressively low. Would the target size range have an affect? We are sampling just 500 genes and not a whole exome. I've noticed PCR duplicates from 14% to 50% in our data. I am trying to convince the wet lab people to lower their PCR cycles.

      How many cycles are you doing? I think wetlab is doing 16 cycles..

      Comment

      • Heisman
        Senior Member
        • Dec 2010
        • 534

        #4
        If we can start with 3ug DNA we can get away with 7 or fewer PCR cycles. The protocol states to do 4-6 but when I've done 8 cycles I haven't had any issues. 16 prior to hybridization seems quite high, though. I communicated with an Agilent rep who told me that duplicates are mainly caused by too many cycles pre-hyb.

        Comment

        • Robby
          Member
          • Mar 2011
          • 68

          #5
          Hi,
          I think the number of reads and the target region size is important as well.

          But nevertheless we have the duplication problem as well. We used the Agilent AllExon-Kit and sequenced with the HiSeq (one lane per sample). We observed a duplication rate of 40-50%, although we sticked to the protocol. We observe, that the duplication rate with the GA II is much lower than with the HiSeq. Does anyone observe the same?

          How many reads did you map to which region size and which duplication rate did you observe?

          @Heisman: Did you sequence with the HiSeq or the GA II? How many reads did you receive?

          Comment

          • Heisman
            Senior Member
            • Dec 2010
            • 534

            #6
            @Robby: We sequence with the HiSeq and I get generally ~90-100 million reads. We map to the whole genome using novoalign but that shouldn't be a determining factor regarding how many duplicate reads there are. I have no idea why you are getting so many duplicates or, even more interestingly, why you would get less duplicates with the GAIIx. I've generally started with 3-4 ug DNA and done 7-8 PCR cycles pre-hybridization (around 12 after hybridization).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
              by SEQadmin2




              NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
              Today, 06:46 AM
            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-28-2026, 09:57 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-28-2026, 09:51 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            67 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            47 views
            0 reactions
            Last Post SEQadmin2  
            Working...